9 December, 2013    london , United Kingdom
Biosimilar markets are increasingly attracting more interest and are seen as a new industry for some generic companies to exploit, as these companies attempt to adjust to the high competition and low profit margins found in the commodity generics market. Less regulated markets have seen biosimilars take off in recent years; however this is not the case across Europe and the US where regulatory barriers have slowed the development of this industry in these markets.

SMi's masterclass hosted by Interpharm Consultancy, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US. Case study led and extremely informative, Peter Wittner looks to help identify both successful and unsuccessful applications in regards to biosimilar regulatory approval in a bid to better inform attendees of how they might approach.

Contact Fateja Begum
Tel: +44 (0) 20 7827 6184
Email: [email protected]


Category: Conferences

Price: £599

Time: 8:50 am - 1:00 pm

Speaker: Peter Wittner

Venue

Location: Holiday Inn London Bloomsbury
Friendly and attentive hotel staff, a great location in the heart of London right next to Russell Square underground station and well maintained facilities all contributes to making the Holiday Inn..
Contact Coram Street, London WC1N 1HT, United Kingdom london , United Kingdom
+44 870 400 9222

Related events

Biosimilars - Commercial Strategies and Regulatory Guidelines 9 December, 2013